Categories: Alzheimer's


WSJ offers caution early and often in coverage of latest experimental Alzheimer’s drug


ABC downplays gloomy context in reporting ‘remarkable’ BACE1 finding for Alzheimer’s


Unlike many other news sites, NPR resists overstating results of Alzheimer’s study


More backstory needed on study of ‘brain training’ benefits for dementia

1 9/28/2015

With just 226 words, NYT can’t deliver needed context on Alzheimer’s agitation study


Resveratrol “may slow Alzheimer’s”? Not really


Over-the-top headline aside, CNN frames resveratrol/Alzheimer’s study in cautious, accurate language

1 8/15/2015

FDA approves first computer-based dementia assessment aid; thorough Post report falls just short on key aspects of coverage

1 8/12/2015

Important Alzheimer’s topic needed a second source for context

1 7/24/2015

WSJ business story on Alzheimer’s drugs missed key aspects of health angle